Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers (PIPOX)
Phase I / II Dose Escalation of Oxaliplatin Via a Laparoscopic Approach of Aerosol Pressurized Intraperitoneal Chemotherapy for Nonresectable Peritoneal Metastases of Digestive Cancers (Stomach, Hail and Colorectal)
Sponsor: Institut Cancerologie de l'Ouest
Terminated
The 34 patients included had all completed their treatment period under the protocol and the data could be collected to assess the main objective and the secondary objectives before the last theoretical follow-up.
Other terminated trials from Institut Cancerologie de l'Ouest
Other Digestive Cancer trials with similar outcome
This PHASE1/PHASE2 trial investigates Digestive Cancer and is currently terminated or withdrawn. Institut Cancerologie de l'Ouest leads this study, which shows 8 recorded versions since 2017 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
May 2022 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
Status: Unknown Status → Terminated
-
Oct 2021 — May 2022 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 3 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE1_PHASE2
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut Cancerologie de l'Ouest
For direct contact, visit the study record on ClinicalTrials.gov .